期刊文献+

吗啡对小鼠骨癌痛模型破骨细胞相关因子RANKL表达的影响 被引量:3

EFFECT OF MORPHINE ON THE EXPRESSION OF OSTEOCLAST ASSOCIATED CYTOKINE RANKL IN A MOUSE MODEL OF BONE CANCER
下载PDF
导出
摘要 目的:建立小鼠骨癌痛模型,并给予吗啡处理,观察破骨细胞相关因子RANKL的表达,探讨痛觉过敏产生的机制。方法:建立雄性小鼠股骨癌痛模型,自造模后第1天起每天测量机械痛敏阈值,在第7天分别按每天给予吗啡20,10,3和1mg/kg将模型随机分为癌痛Ⅰ,Ⅱ,Ⅲ和Ⅳ四组(n=8)。利用RT-PCR和免疫组化法分别检测RANKL mRNA的表达和RANKL蛋白的表达。结果:第7天癌痛各组与对照组相比疼痛阈值有显著降低(P<0.05),应用吗啡后前4天疼痛阈值与对照组无差异,后3天癌痛Ⅰ组与对照组相比疼痛阈值降低有显著差异(P<0.05);癌痛各组随吗啡剂量增加RANKL表达增加,癌痛Ⅰ、Ⅱ组与对照组相比有显著性(P<0.05)。结论:RANKL可能与痛觉过敏的产生有关系。 Objective : To establish a model of bone cancer pain with mouse and treat them with morphine to evaluate the mechanism of hyperalgesia by observing the expression of RANKL. Methods : Model of femur bone cancer pain was made with male mice. Pain threshold of mechanical hyperalgesia was measured since the first day after the model being made. Morphine was administrated with dose of 20,10, 3st and1 mg/kg/day, respectively and divided into Ⅰ, Ⅱ, Ⅲ, Ⅳfour groups ( n = 8 ) randomly at the seventh day. Results : Pain threshold of cancer pain group declined compared with the control group ( P 〈 0.05 ). However, there was no significant difference of the pain threshold between cancer pain group and control group at the previous four days after treatment with morphine. But pain threshold of cancer pain Ⅰ group was significantly declined compared with the control group in the last three days (P 〈 0.05 ). RANKL expression increased with the morphine dose increaed in cancer pain groups and expression increased significantly in cancer pain group Ⅰ , Ⅱcampared with the control group. Conclusion:RANKL may play a important role in the process of hyperalgesia.
出处 《中国疼痛医学杂志》 CAS CSCD 2009年第1期39-42,共4页 Chinese Journal of Pain Medicine
关键词 吗啡 骨癌模型 RANKL 痛觉过敏 Morphine Animal model of bone cancer RANKL Hyperalgesia
  • 相关文献

参考文献9

  • 1Tamara King, Anna Vardanyan, Lisa Majut, et al. Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. 2007, 132 : 154-168.
  • 2Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol,2005,5 : 618 -625.
  • 3马正良,夏小萍,朱巍,业光衡,韩鹂,费强.小鼠骨癌痛模型的建立及痛行为学和骨损害的观察[J].中国疼痛医学杂志,2007,13(5):288-292. 被引量:18
  • 4Johnston IN, Milligan ED, Wieseler-Frank J, et al. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. Neurosei, 2004. 24 :7353-7365.
  • 5Juni A, Klein G, Kest B. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems. Brain Res, 2006, 1070 : 35 -44.
  • 6Rous S, Amazit L, Meduri G, et al. RANK (receptor activatior of nuclear factor kappa B ) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol, 2002, 117 : 210 -216.
  • 7Brown JM, Corey E, Lee ZD, et al. Osteoprote-gerin and rank ligand expression in prostate cancer. Urology, 2001, 57 : 611-616.
  • 8Luger NM, Mach DB, Sevcik MA, et al. Bone cancer pain: from model to mechanism to therapy. Pain Symptom Manage, 2005,29 :S32 - 46.
  • 9Toyas A, Ollikainen J, Taskinen M, et al. Inhibition of them evalonate pathway is involved in alendronate-induced cell growth inhibition, but not in cyto-kine secretion from macrophages in vitro. Eur J Phan Sci,2003,19:223 -230.

二级参考文献14

  • 1Iguchi H,Onuma E,Sato K,et al.Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancerderived cell line established from a bone metastasis specimen.Int J Cancer,2001,94:24 -27.
  • 2Clohisy DR,Ramnaraine ML,Scully S,et al.Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice.J Orthop Res,2000,18:967 - 976.
  • 3Mantyh PW.Clohisy DR,Koltzenburg M,et al.Molecular mechanisms of cancer pain.Nat Rev Cancer,2002,2:201 - 209.
  • 4Luger NM,Mach DM,Sevcik,BA,et al.Bone cancer pain:from model to mechanism to therapy.J Pain and Symptom Manag,2005,29:S32-46.
  • 5Mercadante S.Malignant bone pain:pathophysiology and treatment.Pain,1997,69:1 - 18.
  • 6Mercadante S,Arcuri E.Breakthrough pain in cancer patients:pathophysiology and treatment.Cancer Treat Rev,1998,24:425 -432.
  • 7Portenoy RK,Lesage P.Management of cancer pain.Lancet,1999,353:1695 - 1700.
  • 8Banning A,Sjogren P,Henriksen H.Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic.Pain,1991,45:45 -48.
  • 9Coleman RE.How can we improve the treatment of bone metastases further? Curr Opin Oncol,1998,0:S7- 13.
  • 10Coleman RE,Houston S,Purohit OP,et al.A randomised phase Ⅱ study of oral pamidronate for the treatment of bone metastases from breast cancer.Eur J Cancer,1998,34:820 -824.

共引文献17

同被引文献31

  • 1宋雪松,徐艳冰,曹君利,何建华,张励才,曾因明.cAMP反应元件结合蛋白介导磷酸化细胞外信号调节激酶在神经病理性痛形成中的作用[J].生理学报,2005,57(2):139-146. 被引量:16
  • 2Schwei MJ, Honore P, Rogers SD, et al. Neuro- chemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci, 1999, 19 : 10886- 10897.
  • 3Clohisy DR, Ramnaraine ML, Scully S, et al. Os- teoproteger in inhibits tumor-induced osteoclasto- genesis and bone tumor grow th in osteopetrotic mice. J O rthop Res, 2000, 18 : 967 - 976.
  • 4Mantyh PW. Clohisy DR, KoltzenburgM, et al. Molecular mechanisms of cancer pain. Nat Rev Cancer, 2002, 2 : 201 - 209.
  • 5Schwei M J, Honore P, Rogers SD, et al. Neuro- chemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Ne- urosci 1999, 19 : 10886- 10897.
  • 6Luger NM, Mach DM, Sevcik, BA, et al. Bone cancer pa in: from model to mechanism to therapy. J Pain and Symptom Manag, 2005, 29 : S32 - 46.
  • 7Mantyh PW. A mechanism-based understanding of bone cancer pain. Novartis Found Symp, 2004, 261 : 194 - 214; discussion 214 - 219,256 - 261.
  • 8Olson TH, Riedl MS, Vulchanova L, et al. An acid sensing ion channel(ASIC)localizes to small prim- ary afferent neurons in rats. Neuroreport, 1998, 9 : 1109 - 1113.
  • 9Shinoda M, Ogino A, Ozaki N, et. al Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain. J Pain. 2008, 9 : 687 - 699.
  • 10Tong W, Wang W, Huang J, et .al Spinal high- mobility group box 1 contributes to mechanical al- lodynia in a rat model of bone cancer pain. Bio- chem Biophys Res Commun. 2010, 395 : 572- 576.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部